Unknown

Dataset Information

0

Elucidation of the Biotransformation Pathways of a Galnac3-conjugated Antisense Oligonucleotide in Rats and Monkeys.


ABSTRACT: Triantennary N-acetyl galactosamine (GalNAc3) is a high-affinity ligand for hepatocyte-specific asialoglycoprotein receptors. Conjugation with GalNAc3 via a trishexylamino (THA)-C6 cluster significantly enhances antisense oligonucleotide (ASO) potency. Herein, the biotransformation, disposition, and elimination of the THA cluster of ION-681257, a GalNAc3-conjugated ASO currently in clinical development, are investigated in rats and monkey. Rats were administered a single subcutaneous dose of (3)H-radiolabeled ((3)H placed in THA) or nonradiolabeled ION-681257. Mass balance included radiometric profiling and metabolite fractionation with characterization by mass spectrometry. GalNAc3-conjugated ASOs were extensively distributed into liver. The THA-C6 triantenerrary GalNAc3 conjugate at the 5'-end of the ASO was rapidly metabolized and excreted with 25.67?±?1.635% and 71.66?±?4.17% of radioactivity recovered in urine and feces within 48 hours postdose. Unchanged drug, short-mer ASOs, and linker metabolites were detected in urine. Collectively, 14 novel linker associated metabolites were discovered including oxidation at each branching arm, initially by monooxidation at the ?-position followed by dioxidation at the ?-arm, and lastly, tri and tetra oxidations on the two remaining ?-arms. Metabolites in bile and feces were identical to urine except for oxidized linear and cyclic linker metabolites. Enzymatic reaction phenotyping confirmed involvement of N-acetyl-?-glucosaminidase, deoxyribonuclease II, alkaline phosphatase, and alcohol + aldehyde dehydrogenases on the complex metabolism pathway for THA supplementing in vivo findings. Lastly, excreta from monkeys treated with ION-681257 revealed the identical series as observed in rat. In summary, our findings provide an improved understanding of GalNAc3-conjugated-ASO metabolism pathways which facilitate similar development programs.

SUBMITTER: Shemesh CS 

PROVIDER: S-EPMC5014515 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Elucidation of the Biotransformation Pathways of a Galnac3-conjugated Antisense Oligonucleotide in Rats and Monkeys.

Shemesh Colby S CS   Yu Rosie Z RZ   Gaus Hans J HJ   Greenlee Sarah S   Post Noah N   Schmidt Karsten K   Migawa Michael T MT   Seth Punit P PP   Zanardi Thomas A TA   Prakash Thazha P TP   Swayze Eric E EE   Henry Scott P SP   Wang Yanfeng Y  

Molecular therapy. Nucleic acids 20160510


Triantennary N-acetyl galactosamine (GalNAc3) is a high-affinity ligand for hepatocyte-specific asialoglycoprotein receptors. Conjugation with GalNAc3 via a trishexylamino (THA)-C6 cluster significantly enhances antisense oligonucleotide (ASO) potency. Herein, the biotransformation, disposition, and elimination of the THA cluster of ION-681257, a GalNAc3-conjugated ASO currently in clinical development, are investigated in rats and monkey. Rats were administered a single subcutaneous dose of (3)  ...[more]

Similar Datasets

| S-EPMC4345304 | biostudies-literature
| S-EPMC7192618 | biostudies-literature
2023-05-10 | PXD025957 | Pride
| S-EPMC7427431 | biostudies-literature
| S-EPMC6154734 | biostudies-literature
| S-EPMC4593562 | biostudies-literature
| S-EPMC7891411 | biostudies-literature